Cargando…

Moral motivation regarding dementia risk testing among affected persons in Germany and Israel

Recent advances in biomarkers may soon make it possible to identify persons at high risk for late-onset Alzheimer’s disease at a presymptomatic (preclinical) stage. Popular demand for testing is increasing despite the lack of cure and effective prevention options and despite uncertainties regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Alpinar-Sencan, Zümrüt, Schicktanz, Silke, Ulitsa, Natalie, Shefet, Daphna, Werner, Perla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626915/
https://www.ncbi.nlm.nih.gov/pubmed/34290115
http://dx.doi.org/10.1136/medethics-2020-106990

Ejemplares similares